Join the research team
and Be a part of the breast cancer solution.
We’re proud to announce that we’ve been awarded a major grant and are partnered with USC Norris to Launch the Eileen McGeever Breast Cancer Survivorship Program.
We need your help to get 1,000 eligible candidates for our study.
Over 40,000 women die annually
In the United States, more than 40,000 women lose their life to breast cancer each year, but that does not have to be the case.
Here’s what you should know
90% Five Year Survival Rate
The 5-year survival rate for early stage breast cancer is at an all time high at around 90%
22% Survival Rate if Cancer Returns
The 5-year survival rate for breast cancer that returns plummets to around 22%
90% of deaths due to breast cancer recurrence
More than 90% of deaths are due to breast cancer returning to a distant site in the body. When breast cancer spreads to other parts of the body it is called metastatic breast cancer.
Up to 30% of women will develop a metastatic recurrence
Up to three out of every ten women diagnosed with invasive breast cancer will develop a recurrence.
Eileen McGeever Breast Cancer Survivorship Program.
This program offered at the Norris Comprehensive Cancer Center of USC aims to assist female participants with supportive care and educational resources in order for our team to study the possible reasons contributing to the return of cancer.
With approximately 90% of breast cancer deaths due to metastasis, the Eileen McGeever Breast Cancer Survivorship Program aims to integrate survivorship care and research. This multi-ethnic program will further the development of a potential blood-based test for detecting tumor DNA that indicates cancer’s recurrence and spread.
Want to learn more or get involved?
Help end breast cancer mortality due to recurrence
Participate in our blood drive
Become a long-term member of our translational research team
We need 500 breast cancer survivors to donate blood and join our team. Take the survey below to find out whether you are eligible for the blood drive.
If you’ve had breast cancer within the last 7 years, you are not currently on chemotherapy and have not had another kind of cancer, you may be eligible to donate blood!
There are no borders for this event. If you can be at the event on November 16, 2019, it doesn’t matter where you live. However, we are working out details to allow remote blood collection for our next blood drive.
We are working on a Blood test to predict whether breast cancer will spread to other organs
Translational research vs. trans-relational research
Translational Research is the journey of bench to bedside. In other words, it is the process that starts with a discovery on the laboratory bench and ends with a novel clinical test or medical intervention for the patient at the bedside.
The use of biospecimens and associated data for research entails significant ethical obligations to the individuals from whom those specimens were obtained. Researchers owe it to themselves and to their benefactors to provide information as soon as it becomes available.
Trans-Relational research is the journey of bench with bedside. In a cumulative effort to augment patient/researcher relationship, increase the transparency of research, send a strong message of hope to patients and conduct a highly translational research project, I am launching The Bench with Bedside Initiative™. The process here represents a new research model whereby the researcher at the Bench interacts more closely with the patient at the Bedside.
Follow the research results of your blood sample Collaborate with scientists We want your input We want transparency
The Bench with Bedside Initiative™
A patient-scientist collaboration
Are you curious about what happens with your blood sample after you donate? Do you want to know what the results of the research are?
In addition to cutting edge science, we believe that improving the relationship between the researcher and the patient is integral to the success of the study and ending breast cancer.
The Benefits of Getting involved:
- Follow the study to the end and access the results of the study in real-time.
- Tell us how you are doing and update us on your journey.
- You will learn about the outcomes of the research including its successes and failures – an effort to enhance the transparency of biomedical research.
- You will get to know the researchers and they will get to know you. We want to augment the patient/researcher relationship which we believe has tremendous benefits. We will share our stories and build a strong collaborative team.
- Gain knowledge into your disease and be a part of the solution
- HOPE! We want this experience to give you lots of hope!
We want you to donate your blood, but we also want to invite you into the research process. Let’s work together to solve an important problem in the field – predicting recurrence and how to prevent it.
Learn more about The Bench with Bedside Initiative™ or the research project by clicking the links below.
Donate Blood & Join the research team
If you have stage IV breast cancer or have completed therapy and have early stage breast cancer, take our eligibility survey and sign up to donate blood & join the research team
Help Spread The Word
We need your help getting the word out there! Share this website with your friends, family, co-workers, and anyone else passionate about ending breast cancer
Breast cancer research costs money. Support this project financially to ensure we have the resources necessary to complete our study towards ending breast cancer
Department of Translational Genomics
The Department of Translational Genomics and Institute of Translational Genomics at Keck School of Medicine of the University of Southern California is focused on translating the molecular study of genes into individual treatment plans.